In the January 2011 issue of Nature Medicine, the article entitled “Funds go toward biomedical business incubators in Mexico” (Nat. Med. 17, 7, 2011) specified that UNAM scientists had donated 15 million pesos of their own money into a fund for startup companies; however, the correct amount was 5.5 million pesos. Additionally, the piece incorrectly stated that Biohominis created the H1N1 diagnostic kits, when in fact this was done by scientists at UNAM's Biotechnology Institute. Last, the National Science and Technology Council did not provide funding for the development of the H1N1 kits as stated in the text. The errors have been corrected in the HTML and PDF versions of the article.
In the January 2011 issue of Nature Medicine, the article entitled “Scarred by disease” (Nat. Med. 17, 18–20, 2011) stated that the STX-100 compound from Stromedix is a small-molecule drug. However, the drug is actually a monoclonal antibody. The error has been corrected in the HTML and PDF versions of the article.